Ministry of Defence of the Republic of India

12/31/2025 | Press release | Distributed by Public on 12/30/2025 23:56

India’s first 3D Flex Aqueous Angiography with iStent performed by Army Hospital (Research & Referral)

Ministry of Defence

India's first 3D Flex Aqueous Angiography with iStent performed by Army Hospital (Research & Referral)

Posted On: 31 DEC 2025 11:09AM by PIB Delhi

In a landmark achievement for Indian medicine, the Ophthalmology Department at Army Hospital (Research & Referral), Delhi Cantt has successfully performed India's first-ever 3D Flex Aqueous Angiography with iStent, combining advanced imaging with minimally invasive glaucoma surgery. Conducted with the new stand-mounted Spectralis system and a state-of-the-art 3D operating microscope, this pioneering procedure places the Armed Forces Medical Services at the forefront of global ophthalmic care.

Glaucoma, a leading cause of irreversible blindness, has long challenged clinicians with its silent progression. This breakthrough offers unprecedented real-time visualisation of aqueous outflow pathways, enabling surgeons to deliver precise, targeted interventions and significantly improve patient outcomes.

As the first-of-its-kind in the country, the integration of 3D Flex Aqueous Angiography with iStent, a Minimally Invasive Glaucoma Surgery sets a new benchmark in glaucoma care, ensuring enhanced intraoperative imaging, and better long-term results. For the Armed Forces community, it represents not only a medical milestone but also a strategic leap in safeguarding vision and operational readiness.

*********

SR/Savvy


(Release ID: 2209996) Visitor Counter : 68
Ministry of Defence of the Republic of India published this content on December 31, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 31, 2025 at 05:57 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]